Vitalibis Verschuldung / Eigenkapital
Was ist das Verschuldung / Eigenkapital von Vitalibis?
Verschuldung / Eigenkapital von Vitalibis, Inc. ist -1.43
Was ist die Definition von Verschuldung / Eigenkapital?
Die Verschuldung zu Eigenkapital ist ein Finanzverhältnis, das den relativen Anteil des Eigenkapitals und der Verschuldung angibt, die zur Finanzierung der Vermögenswerte eines Unternehmens verwendet werden.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Verschuldung / Eigenkapital von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Vitalibis
Was macht Vitalibis?
Vitalibis, Inc. operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. The company markets and sells consumer products under the Vitalibis brand. It also sells water soluble phytocannabinoid rich hemp powder. The company was formerly known as Sheng Ying Entertainment Corp. and changed its name to Vitalibis, Inc. in February 2018. Vitalibis, Inc. was founded in 2014 and is based in Las Vegas, Nevada. On June 15, 2020, Vitalibis, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.
Unternehmen mit verschuldung / eigenkapital ähnlich Vitalibis
- Stagezero Life Sciences Ltd hat Verschuldung / Eigenkapital von -1.44
- Dragon King hat Verschuldung / Eigenkapital von -1.44
- Pathfinder Minerals Plc hat Verschuldung / Eigenkapital von -1.44
- U.S. Lithium hat Verschuldung / Eigenkapital von -1.43
- GINSMS hat Verschuldung / Eigenkapital von -1.43
- Galectin Therapeutics Inc hat Verschuldung / Eigenkapital von -1.43
- Vitalibis hat Verschuldung / Eigenkapital von -1.43
- Landcadia II hat Verschuldung / Eigenkapital von -1.42
- Norwood Systems hat Verschuldung / Eigenkapital von -1.42
- Omkar Speciality Chemicals hat Verschuldung / Eigenkapital von -1.42
- iSIGN Media Solutions hat Verschuldung / Eigenkapital von -1.42
- Ecoark hat Verschuldung / Eigenkapital von -1.42
- Orege Societe Anonyme hat Verschuldung / Eigenkapital von -1.42